Alimentary Pharmacology & Therapeutics · 2022 · 21 citations · 10 references
PharmacyInternal MedicinePharmacotherapyClinical EpidemiologyDrug Utilization ReviewMedication Safety PolicyCorticosteroid PharmacologyCorticosteroid TherapyInflammatory Bowel DiseaseInflammatory Bowel Disease CareSteroid PharmacologyAppropriate PrescribingCare For The PoorClinical Adverse EffectsComparative Efficacy Of CorticosteroidsPrimary Care PathwaysSecondary Care ReferralSteroid Adverse EffectsSteroid Therapy Management
BACKGROUND: Corticosteroids remain important for managing inflammatory bowel disease (IBD) flares. Steroid excess, however, may be a marker of poor care. Patients access steroid prescriptions from primary (General Practitioners [GP]) or secondary care (hospital-based). Sources of prescriptions and associated outcomes are not well described. METHODS: Patients attending IBD clinics with linked primary care information were included. We examined appropriateness and timeliness of treatment escalation and avoidability of steroid excess in relation to prescription sources. RESULTS: Of 2246 patients, 33% were exposed to steroids over 2 years. Primary care issued 28% of prescriptions. Secondary care prescriptions were more often of appropriate dose and duration (85% vs 41%, p < 0.001). Further flares occurred in 50% of patients prescribed steroids from primary care (vs 39%; p = 0.003). Steroid excess was observed in 15%. Patients with steroid excess who received prescriptions from primary care that were not communicated to secondary care less often received timely treatment escalation (49% vs 66%, p = 0.042) and steroid excess was more often avoidable (73% vs 56%, p = 0.022). Patients with steroid excess had higher risks of hospitalisation for IBD (OR = 12.33, 95% CI [8.89-17.11]), hospitalisation for infections (OR = 2.89, 95% CI [1.82-4.61]) and GP prescribed antibiotics (OR = 1.41, 95% CI [1.07-1.86]). CONCLUSION: Patients commonly access steroids through primary care, but doses and durations are frequently inappropriate with patients more likely to flare. Steroid excess was associated with IBD admissions, admissions for infections and antibiotic prescriptions. Improved liaison between primary and secondary care is required to reduce steroid excess.
10
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Joana Torres, Stefanos Bonovas, Glen Doherty et al. · Journal of Crohn s and Colitis · 2019 · 1.3K citations · Full text
PREDNISONE AS MAINTENANCE TREATMENT FOR ULCERATIVE COLITIS IN REMISSION
J E Lennard‐Jones, J J Misiewicz, Alastair M. Connell et al. · The Lancet · 1965 · 195 citations
Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
Akbar K. Waljee, Wyndy L. Wiitala, Shail M. Govani et al. · PLoS ONE · 2016 · 170 citations · Full text